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Background: The transcription factor Pax8 is essential for the differentiation of thyroid cells. However, there are few
data on genes transcriptionally regulated by Pax8 other than thyroid-related genes. To better understand the role of
Pax8 in the biology of thyroid cells, we obtained transcriptional profiles of Pax8-silenced PCCl3 thyroid cells using
whole genome expression arrays and integrated these signals with global cis-regulatory sequencing studies
performed by ChIP-Seq analysis
Results: Exhaustive analysis of Pax8 immunoprecipitated peaks demonstrated preferential binding to intragenic
regions and CpG-enriched islands, which suggests a role of Pax8 in transcriptional regulation of orphan CpG
regions. In addition, ChIP-Seq allowed us to identify Pax8 partners, including proteins involved in tertiary DNA
structure (CTCF) and chromatin remodeling (Sp1), and these direct transcriptional interactions were confirmed
in vivo. Moreover, both factors modulate Pax8-dependent transcriptional activation of the sodium iodide symporter
(Nis) gene promoter. We ultimately combined putative and novel Pax8 binding sites with actual target gene
expression regulation to define Pax8-dependent genes. Functional classification suggests that Pax8-regulated genes
may be directly involved in important processes of thyroid cell function such as cell proliferation and differentiation,
apoptosis, cell polarity, motion and adhesion, and a plethora of DNA/protein-related processes.
Conclusion: Our study provides novel insights into the role of Pax8 in thyroid biology, exerted through
transcriptional regulation of important genes involved in critical thyrocyte processes. In addition, we found new
transcriptional partners of Pax8, which functionally cooperate with Pax8 in the regulation of thyroid gene
transcription. Besides, our data demonstrate preferential location of Pax8 in non-promoter CpG regions. These data
point to an orphan CpG island-mediated mechanism that represents a novel role of Pax8 in the transcriptional
output of the thyrocyte.
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Gene regulation has been the subject of intense investi-
gation over the past decades, mainly focusing on detailed
characterization of a particular gene or gene family.
However, genome-wide mapping of protein-DNA inter-
actions and epigenetic marks is essential for a full under-
standing of transcriptional regulation. A precise map of
binding sites for transcription factors (TFs), core tran-
scriptional machinery, and other DNA-binding proteins* Correspondence: psantisteban@iib.uam.es
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distribution, and reproduction in any mediumis necessary to decode the gene regulatory networks and
their contribution to developmental processes and
human disease [1]. In fact, regulation of gene expression
by TFs is one of the major mechanisms for controlling
cell proliferation, differentiation, and function.
To elucidate the mechanism(s) operating in the es-
tablishment and maintenance of cell-specific differen-
tiation, we used thyroid epithelial cells as a model
system. These cells are the largest cell population of
the thyroid gland and express different TFs called
Nkx2.1, Foxe1, Hhex and Pax8, which define the thy-
roid differentiated phenotype [2,3]. It is well known
that these factors bind to the promoter regions of
thyroid-specific genes, such as the genes encodingentral Ltd. This is an Open Access article distributed under the terms of the
creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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http://www.biomedcentral.com/1471-2164/13/147Thyroglobulin (Tg), Thyroperoxidase (Tpo), and the
Sodium Iodide Symporter (Nis), thus regulating their
expression. Nevertheless, despite the key relevance of
these TFs for thyroid biology, few studies have
described additional loci that are transcriptionally
regulated by the above mentioned TFs, nor have
sequences been described to which these factors bind
in enhancers, silencers, or boundary elements that
could potentially regulate the transcription of genes
over large distances.
Among these thyroid TFs, Pax8 is a member of the
paired box-containing proteins and is expressed in
the thyroid and kidney, and in the central nervous
system during development [4]. It plays an essential
role in the differentiation of thyroid cells and,
according to the phenotype of Pax8 knockout mice,
it seems to be responsible for the formation of the
follicles of polarized epithelial thyroid cells [5]. Also,
the association between mutations of PAX8 and con-
genital hypothyroidism in humans underlines an im-
portant function of this transcription factor in
thyroid pathologies [6]. In order to better understand
its role in the maintenance of thyroid function, we
explored the transcriptional profile of Pax8-silenced
thyroid cells, and integrated these signals with global
cis-regulatory sequencing studies (chromatin immu-
noprecipitation followed by sequencing; ChIP-Seq).
The ChIP-Seq strategy allowed us to identify a large
number of novel in vivo Pax8 binding sites that were sig-
nificantly associated with CpG islands or high GC con-
tent sequences. Interestingly, immunoprecipitated peaks
were mainly located along intronic regions and grouped
in distal positions with respect to transcriptional start
sites. Consensus sequence screening of these areas sug-
gested Pax8 interaction with several core transcriptional
elements (motif ten element, Inr, and BRE), transcription
factors belonging to the AP1 family, and trans-elements
factors involved in high order chromatin structure
(CTCF) and remodeling (Sp1). Co-immunoprecipitation
and reporter assays demonstrated both physical binding
and transcriptional cooperation between CTCF/Sp1 and
Pax8. Combining sequencing and expression array data,
we ultimately provided insights into Pax8-transcriptional
networks in the differentiated thyroid that predict its in-
volvement in relevant biological processes and pathways.
Results
Genomic features associated with Pax8 binding sites
In order to identify the genome-wide binding patterns of
Pax8 in differentiated thyroid cells, we performed ChIP-
Seq in PCCl3 rat thyrocytes using IP and non-IP condi-
tions. Prior to massive sequencing, both conditions were
interrogated to verify Pax8 binding site enrichment by
means of semi-quantitative PCR (Additional file 1).Using this approach, we confirmed DNA immunopreci-
pitation of Pax8 binding regions in the rat Nis and Tpo
promoters (Additional file 1A), as previously described
[7-9]. Therefore, we considered both IP and non-IP con-
ditions as useful samples to further identify whole gen-
ome Pax8 binding sites by means of high throughput
sequencing technology. After sequencing analysis, we
obtained 11,613,355 and 12,125,758 raw reads for control
and IP conditions, respectively. Of these, 6,714,002
(57.8%) and 6,431,519 (53.0%) fulfilled the ≤2 mis-
matches quality filter.
To further localize regions of Pax8 enrichment, we
identified Pax8 peaks genome-wide. Peak detection ana-
lysis using MACS defined 13,151 Pax8-enriched regions
with an average length of 681 bp (Additional file 2). Vis-
ual inspection of the Pax8 binding sites and the profiling
data in a genome browser for well-known Pax8 targets
like Nis, Tpo, [7,9] and WT1 (Wilms' tumour gene 1)
[10], showed Pax8 binding sites close to the 5'-UTRs of
these genes as previously described. A detailed analysis
of Nis (Slc5a5, Na+/I− symporter), whose transcription
status is tightly regulated by Pax8 [7], showed a signifi-
cant Pax8 binding site overlapping with the Nis upstream
enhancer (Additional file 1B). These findings clearly vali-
dated ChIP-Seq as an efficient and powerful technique
for mapping Pax8 binding sites in PCCl3 cells.
Association of Pax8 enriched regions with anno-
tated genomic features indicated that Pax8 tends to
localize within intronic regions (82%); only a few
peaks revealed binding to coding (6%) or 5'-UTR
regulatory regions (2%) (Figure 1). In addition, Pax8
binding sites showed preferential binding to regions
located 10-100 kb upstream or downstream of the
closest transcription start site (Figure 1). We also
assessed the general sequence content of these peaks,
including CG content and dinucleotide frequencies.
We found a clearly increased correlation between
Pax8 binding sites and CpG islands (Figure 2A) and
CG simple repeat elements (Figure 2B) in compari-
son with other dinucleotide combinations throughout
the rat genome (Figure 2C and 2D). All these data
suggest preferential Pax8 interaction with “orphan”
CGIs, CG-rich intragenic elements not associated to
5'-UTR regions [11].
Pax8 immunoprecipitated regions delineate Pax8
consensus core sequence in vivo
We considered the most significant Pax8 peaks
(Additional file 3) to evaluate how efficiently ChIP
immunoprecipitated the Pax8-DNA binding se-
quence. Among the most significant consensus
motifs obtained using the MEME-chip and
TOMTOM in silico tools, we observed a significant
overrepresentation of Pax-related binding sites,
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Figure 1 MACS IP peaks characteristics. Diagrams show percentage of peaks overlapping with gene features (left), or their location with regard
to the closest transcription start site (TSS) (right).
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http://www.biomedcentral.com/1471-2164/13/147including sites for Pax8 and members of its own
subfamily (Pax2 and Pax5) (Figure 3). The Pax8
binding motif here defined encompasses motifs
obtained by individual-gene based approaches, such0
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Figure 2 Pax8 immunoprecipitation enrichment. Graphs displaying num
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Figure 3 ChIP-Seq peaks delineate in vivo Pax8 binding site. Image depicts most significant motif defined by the MEME program using the
500 most relevant MACS ChIP-Seq immunoprecipitated peaks and its comparison with Pax proteins-DNA binding consensus sites defined using
in vitro approaches (Czerny et al; Pellizzari et al) [13,14] and previously known Pax8 targets, Nis and Tpo respectively (Ohno et al; Zannini et al)
[7,9]. Underlined characters highlighted in yellow are nucleotides similar between our Pax8 motif and the other consensus sequences.
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http://www.biomedcentral.com/1471-2164/13/147subfamily (AAGCGTGAC) [14]. Of note, our study is the
first to describe the in vivo Pax8 binding sequence derived
from its DNA binding along the whole rat genome.
Immunoprecipitation data reveals interaction of Pax8 with
various TFs
To identify possible interactions between Pax8 and other
TFs, Genomatix suite screening was performed to identify
the most over-represented motifs in the Pax8 binding
regions identified by MACS [15]. Overrepresented consen-
sus motifs in Pax8 peaks, as well as fold change and z-score
values are shown in Table 1 and Additional file 4. These
analyses showed an overrepresentation of the Pax5 (V
$Pax5.1 z-score=87.59, overrepresentation: 2.86; V$Pax5.2
z-score=78.62, overrepresentation: 3.95) and Pax9consensus motifs (V$Pax9.1 z-score=73.71; overrepresenta-
tion: 3.63) with a modest association for Pax8 (V$Pax8.1 z-
score=5.46, overrepresentation: 1.07). These results may be
explained by the DNA binding similarities among members
of the same Pax subfamily (Pax2, Pax5, and Pax8).
In agreement with previous reports describing interac-
tions between members of the Pax family and AP1 factors
[16], we also observed enrichment of transcription factors
belonging to this latter family (V$NRF-1, nuclear respira-
tory factor-1; z-score=146.13, overrepresentation=5.02).
Intriguingly, several transcription factor matrices (V$CTCF,
V$ZF5 and V$SP1F) and general transcriptional regulatory
elements (O$BRE, O$INR-DPE, and Drosophila melanoga-
ster and Homo sapiens Motif ten elements (O$DMTE and
O$HMTE)) showed significant association with Pax8 IP
Table 1 Main DNA binding motifs overrepresented in Pax8-dependent peaks
TF Matrices Family information Matches in Input
(n)
Expected
(genome)
Overrep.
(genome)
Z-Score
(genome)
O$BRE.01 Transcription factor II B (TFIIB) recognition
element
924 88.75 10.41 88.61
O$HMTE.01 Human motif ten element 2481 350.02 7.09 113.88
O$XCPE1.01 X gene core promoter element 1 5454 1531.85 3.56 100.21
O$DMTE.01 Drosophila motif ten element 4415 1442.3 3.06 78.27
O$INR_DPE.01 Initiator (INR) and downstream promoter element
(DPE) with strictly maintained spacing
2460 1071.16 2.30 42.42
V$NRF1.01 Nuclear respiratory factor 1 6640 1323.52 5.02 146.13
V$SP1.02 GC-Box factors SP1/GC; Stimulating protein 1,
ubiquitous zinc finger transcription factor
5792 1090.23 5.31 142.39
V$SP1.03 GC-Box factors SP1/GC; Stimulating protein 1,
ubiquitous zinc finger transcription factor
4802 1129.17 5.14 139.05
V$ZF5.01 Zinc finger / POZ domain transcription factor 5543 1260.88 4.40 120.59
V$CTCF.01 CCCTC-binding factor 4729 1015.47 4.66 116.52
The Overrep. (genome) column represents the fold overrepresentation of these matrices in our IP peaks compared to their presence in the rat genome, and the Z-
Score (genome) column indicates association value between the DNA matrices and Pax8-immunoprecipitated DNA.
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http://www.biomedcentral.com/1471-2164/13/147peaks (Table 1). In order to rule out any nonspecific effect
of the Pax8 antibody on the recognition of these transcrip-
tion factors not related to Pax8, we compared their amino
acid sequences with the Pax8 protein by means of the
DNAStar alignment program. No significant similarities
were observed among the considered proteins, thus ruling
out any unspecific binding of the Pax8 antibody (data not
shown). As shown in their corresponding IP Genomatix
motifs (Figure 4), all these transcription factors preferen-
tially bind to regions with high GC content, which could be
related to the association of Pax8 to CpG islands and CG
repeats.10 155
From MatBase by Genomatix
V$NRF1.01
5
From MatBase by Genomatix
O$BRE.01
105
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O$HMTE.01
V$CTCF.02
Figure 4 Core matrices obtained for different significantly overrepres
immunoprecipitated peaks. Matrices shown include both transcription fa
transcriptional core elements (O$HMTE.01 and O$BRE.01).To validate the interactions between Pax8 and the TFs
described before, we performed co-immuprecipitation
assays in PCCl3 cells using specific antibodies for Pax8,
Sp1 and CTCF. As shown in Figure 5A, both CTCF and
Sp1 coprecipitate with Pax8, confirming physical binding
among these transcription factors in vivo and suggesting
the existence of common transcriptionally regulated tar-
gets. Given that the Nis promoter region conferring
regulation by Pax8 (NIS upstream enhancer) overlapped
with potential sites for both transcription regulators
(data not shown), we performed transfection experi-
ments in HeLa cells using a reporter construct105
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Figure 5 CoIP assays demonstrating physical interaction of Pax8 with Sp1 and CTCF. A) Nuclear extracts from control or hCTCF-transfected
PCCl3 cells were obtained and immunoprecipitated (IP) with anti Pax8, anti-Sp1 or anti-CTCF antibodies. Immunoblotting was performed against
Sp1 (top, left panel), CTCF (top, right panel) or Pax8 (bottom, left and right panels). Lanes 1 are the input and lanes 2 are the nonspecific IPs using
IgG. The Figure shows a representative Western-Blot. B) Reporter assays were performed using the pNIS-2.8 promoter and expression vectors as
indicated in the figure. Promoter activity is expressed as fold induction, relative to the activity observed in the presence of empty expression
vector. The amount of total DNA used for each transfection was adjusted with the matched empty vector control to 1 μg. Luciferase activity was
normalized to renilla activity derived from the cotransfected pRL-CMV vector to adjust for transfection efficiency. Results are mean± SD of three
independent experiments. * p-value< 0.005; **, p-value< 0.01.
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http://www.biomedcentral.com/1471-2164/13/147containing the Nis promoter [17]. As shown in Figure 5B,
Sp1 strikingly increased NIS transcriptional activity,
while cotransfection of Pax8 and Sp1 resulted in a syner-
gestic effect on promoter activation. On the other hand,
contransfection with CTCF induced a statistically signifi-
cant decrease in transcription (Figure 5B). These data
unequivocally demonstrate a functional cooperation be-
tween Pax8 and Sp1 and CTCF in transcriptional
regulation.Expression arrays analysis identifies a wide set of loci
regulated by Pax8
We used whole genome expression arrays to identify
Pax8-regulated genes by comparing expression profiles
of Pax8-silenced PCCl3 cells with both scrambled
siRNA-treated and wild type (wt) PCCl3 cells. This last
condition was included to consistently integrate both ex-
pression array signals and global cis-regulatory sequen-
cing studies into the same experimental conditions.Misinterpretation of expression data due to compensa-
tory effects via Pax8-related paralogues (Pax2 and Pax5)
is ruled out, given that both transcription factors are not
expressed in thyroid cells.
Regarding the comparison of siPax8-PCCl3 vs. wt
PCCl3, 3,035 and 3,354 probes were down and up-regu-
lated in the Pax8-silenced condition, respectively (Add-
itional file 5). A lower number of significant probes was
detected for siPax8-PCCl3 vs. siScramble-PCCl3 (797
and 777 probes were down and up-regulated in the
Pax8-silenced condition, respectively) (Additional file 5).
Statistically significantly differently expressed probes
(adjusted p-values <0.005) for both comparisons
included 633 down and 565 up-regulated targets (Add-
itional file 5), which represent a set of 849 loci.Pax8 is involved in controlling key cellular events
Gene lists were ranked based on t-statistics for gene set en-
richment analysis. The most significant GO terms and
Table 3 KEGG pathways associated to Pax8 silencing
Global class KEGG pathway Scr.
vs Pax8
adj p-value
Wt.
vs Pax8
adj p-value
Downreg.
probes
Phosph. I. Phosphatidylinositol
signaling system
1.28E-03 8.10E-05
Inositol phosphate
metab.
4.18E-02 9.88E-04
Aa metab. Glycine, serine and
threonine metab.
1.25E-04 2.42E-02
Selenoamino acid
metab.
1.61E-03 1.16E-02
Cysteine and
methionine metab.
7.21E-03 1.25E-03
Arginine and proline
metab.
1.06E-02 9.73E-07
Cell cycle Cell cycle 9.67E-05 9.73E-07
CAMs Cell adhesion
molecules
9.37E-03 5.39E-03
Immune
response
Antigen processing
and presentation
1.56E-05 2.86E-03
Autoimmune thyroid
disease
5.26E-04 2.76E-03
DNA/RNA
processes
Purine metab. 1.56E-05 9.52E-09
Base excision repair 5.85E-05 2.20E-03
Pyrimidine metab. 1.25E-04 5.86E-09
Nucleotide excision
repair
2.99E-04 3.22E-03
RNA degradation 9.95E-04 2.76E-03
Mismatch repair 1.22E-03 4.76E-05
Homologous
recombination
2.30E-02 7.50E-03
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http://www.biomedcentral.com/1471-2164/13/147adjusted p-values for both array comparisons are shown in
Table 2, and more detailed data, including genes belonging
to each significant category, are listed in Additional files 6, 7
and 8. In general, the FatiScan tool revealed significant asso-
ciation for biological processes related to immune response,
molecule transport, response to stimuli, cell motion/adhe-
sion, cell proliferation, and translational processes. In rela-
tion to this last term, ribosome-related GO classes were
also observed for other FatiScan categories: molecular pro-
cesses (structural constituent of ribosome; adjusted p-value:
4.43e-13), KEGG pathway (rno-03010; adjusted p-value:
8.7e-6), and cell component analysis (downregulation of
ribosomes and ribonucleoprotein-related genes; GO:
0005840 and 0030529; adjusted p-value: 1.9e-5) (data not
shown).
Single functional analysis
We additionally used the FatiGO in silico tool to ex-
tract Gene Ontology (GO) terms overrepresented in
our down- and up-regulated set of differentially
expressed genes. Considering down-regulated probes
for each comparison, we observed an enrichment in
biological processes related to a wide variety of
DNA, RNA, and protein processes (purine and pyr-
imidine metabolism, response to DNA damage, DNA
replication, nucleotide and base exchange repair, mis-
match repair and homologous recombination, RNA
degradation, and amino acid metabolism), cell re-
sponse to chemical and stress stimuli, immune re-
sponse, and p53 and insulin-related pathways
(phosphatidyl inositol system and metabolism)
(Additional file 9). Concerning GO terms enrichedDNA replication 2.88E-02 2.98E-06
Signaling
pathways
p53 signaling
pathway
7.24E-03 7.26E-07
Upreg.
probes
Cell processes Endocytosis 1.13E-10 4.66E-14
Lysosome 1.23E-06 1.55E-05
Cell
migration/
adhesion
Cell adhesion
molecules
2.43E-09 1.59E-06
Signaling
pathways
Cytosolic DNA-
sensing pathway
4.36E-04 5.70E-06
NOD-like receptor
signaling pathway
2.59E-03 9.17E-05
Toll-like receptor
signaling pathway
4.26E-06 3.52E-07
Chemokine signaling
pathway
1.91E-05 9.22E-06
MAPK signaling 7.52E-06 4.69E-07
Cancer Thyroid cancer 1.65E-02 1.23E-04
Prostate cancer 2.30E-05 4.74E-07
Endometrial cancer 8.49E-04 1.49E-05
Pancreatic cancer 1.34E-05 7.79E-06
Table 2 FatiScan gene set enrichment analysis
Gene Ontology term WT vs Pax8
adj p-value
Scramble vs Pax8
adj p-value
Translation (GO:0006412) 7.10E-12 1.91E-09
Response to external
stimulus (GO:0009605)
2.20E-05 2.02E-07
Response to
wounding (GO:0009611)
2.20E-05 6.87E-05
Cellular component
movement (GO:0006928)
4.97E-03 6.87E-05
Response to hormone
stimulus (GO:0009725)
2.86E-02 1.24E-04
Immune response (GO:0006955) 9.08E-11 1.42E-04
Cell adhesion (GO:0007155) 8.00E-03 6.95E-04
Response to steroid
hormone stimulus (GO:0048545)
2.39E-03 1.99E-03
Antigen processing
and presentation (GO:0019882)
2.00E-05 3.13E-03
Cell migration (GO:0016477) 3.16E-03 3.65E-03
Most significant Gene Ontology (GO) terms overrepresented in both
expression array comparisons. adj p-value: adjusted p-value.
Table 3 KEGG pathways associated to Pax8 silencing
(Continued)
Renal cell carcinoma 1.95E-03 9.22E-06
Colorectal cancer 1.16E-03 4.71E-05
Pathways in cancer 5.20E-06 2.07E-10
Immune
response
Viral myocarditis 2.49E-11 2.68E-08
Graft-versus-host
disease
1.53E-09 5.16E-07
Allograft rejection 9.99E-08 4.28E-06
Autoimmune thyroid
disease
2.53E-08 1.59E-06
Antigen processing
and presentation
1.13E-10 5.06E-13
Most significant KEGG pathways enriched among common downregulated
(n = 633) and upregulated (n = 565) probes for both expression array
comparisons. Downreg.: Downregulated; Upreg.: Upregulated; adj p-value:
adjusted p-value; Phosph.I:Phosphatidylinositol; Aa: Amino acid; metab.:
metabolism.
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http://www.biomedcentral.com/1471-2164/13/147amongst up-regulated probes, it is worth to mention
the over-representation of genes involved in bio-
logical processes such as immune response, cell re-
sponse to stimuli, apoptosis and cell death, cell
motion/migration/adhesion, and regulation of cell
differentiation (Additional file 10).
Table 3 and Additional file 11 depict the most significant
and complete set of KEGG pathways overrepresented in
under and overexpressed target genes, respectively. KEGG
pathways significantly enriched in these Pax8-regulated
genes included vesicle-related terms (endocytosis,
rno004144; lysosomes, rno004142), DNA/RNA events, cell
cycle, cell-cell interactions (focal adhesions, adherens junc-
tions), cancer-related pathways (MAPK, JAK-STAT, p53,
ERBB, TGFβ, and VEGF), amino acid metabolism, and insu-
lin/inositol phosphate signalling events.Integrated data reveal a reduced percentage of genes
transcriptionally regulated through promoter sequences
To answer the question whether independent Pax8 binding
to the genomic regions has functional consequences849 loci
(1198 significant probes
with p-value<0.005)
54  gen
(78 prob
Figure 6 Venn diagram showing the number of significant loci obtain
combined analysis. 78 significant probes (29 and 49 up and down-regulat
<0.05 in the expression arrays and at least one immunoprecipitated peak wthrough changes in the expression level of target genes, the
ChIP-Seq data were integrated with the gene expression
profiling data. As shown in the Venn diagram (Figure 6), 78
differentially expressed probes (29 and 49 up and down-
regulated, respectively, in the siPax8 PCCl3 condition)
representing 54 loci were associated with genes showing a
significant peak around +/− 1 kb from a TSS. This number
of genes represents 6.4% (54 out of 849 genes) of the signifi-
cantly associated genes identified by expression arrays
(Additional file 5). This small overlap can be explained by
indirect effects of Pax8 or by the binding of Pax8 to “or-
phan” CGI regulatory elements, also sites of transcriptional
initiation but not related with TSSs or promoter regions
[11]. It is worth mentioning that we identified neighbouring
genes showing significantly altered expression according to
our expression data, which could be simultaneously regu-
lated by a unique Pax8 binding site; for example, the closely
positioned genes Padi1 and Padi3 (peptidyl arginine deimi-
nase, types I and III) on chromosome 5, andMlph (melano-
philin) and Rab17 on chromosome 9 (Additional file 12).Independent validation confirms significant findings
defined by ChIP-seq and expression arrays
We performed experimental validations using independ-
ent immunoprecipitated and siRNA silenced PCCl3 sam-
ples, as well as their corresponding controls. Among the
genes included for this validation were: Brca1 (breast
cancer 1), a well-known tumour suppressor gene
involved in the maintenance of genomic stability and
related to breast carcinoma development [18]; Cdh16
(cadherin 16, KSP-cadherin), a member of the cadherin
protein family acting as a morphogenic factor for tissue
development [19] and recently described to be regulated
by Pax8 [20,21]; Rab17 (a member of the RAS oncogene
family) and Myo5b (myosin VB), genes previously
described to be involved in epithelial vesicle trafficking
in highly polarized cells [22,23]; Dab2ip (DAB2 interact-
ing protein), a tumour and metastasis suppressor gene
which encodes a Ras GTPase-activating protein [24];
Dio1 (iodothyronine deiodinase, type I), an essential gene942 genes
(with a significant peak
+/- 1Kb from TSS)
es
es)
ed for each screening (expression arrays and ChIP-Seq) and for
ed, respectively, in the siPax8 PCCl3 condition) showed a p-value
ithin 1 kb of a TSS.
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oxidoreductase involved in thyroid hormone activation
by converting the prohormone T4 into bioactive 3,5,3'-
triiodothyronine (T3) [25] and Tmod1 (tropomodulin 1),
a gene encoding a protein which inhibits actin filament
elongation and that is consequently involved in cytoskel-
eton structure regulation and cell morphology [26]. As
shown in Figure 7A, after Pax8 chromatin immunopreci-
pitation followed by semiquantitative RT-PCR, we
observed an enrichment of IP regions for all the above-
mentioned validation targets in comparison with both
non-IP samples and input samples.16
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Figure 7 Experimental validation of ChIP-Seq. A) Normalized IP ratio (ar
peaks of 7 representative genes found in the present analysis. The NUE ele
sequence of the same Nis promoter (NIS-) was used as a negative control.
pannel) and 4 (lower pannel) genes differentially down- and upregulated in
(Scramble) cells, respectively. As a Pax8-dependent positive control, we evaIn addition, Pax8 silencing by means of transient trans-
fection of siRNA was significantly associated with
decreased expression levels of these potential targets
(Figure 7B, upper pannel), thus demonstrating a direct
transcriptional effect of Pax8 on these genes. mRNA ex-
pression validation was also done for several genes that
were upregulated in the absence of Pax8, including the
genes encoding: CCL2, a chemokine involved in thyroid
autoimmunity [27]; S100A4, a calcium-binding protein
which plays a role in angiogenesis, extracellular matrix
remodelling and tumor microenvironment, and reported
to be overexpressed in metastatic papillary thyroid. 3´UTR
DIO1 TMOD1B2IP
Non IP
NIS NIS-
Input
IP
DIO1 TMOD1B2IP
Scramble
NIS
Wild type
siRNAPax8
bitrary units) of corresponding DNA sequences belonging to significant
ment of rat Nis (NIS) was used as a positive control while an unspecific
B) Relative expression assessed by means of qRT-PCR of 7 (upper
Pax8-silenced PCCl3 cells (siRNA Pax8) vs. wild type (wt)/siScramble
luated Nis mRNA expression levels.
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a role in Na+ transport and differentiation in epithelial
cells, respectively [29,30] (Figure 7B, lower panel). In
silico analysis of significant IP peaks located along pro-
moter areas of these loci demonstrated Pax8 potential
binding sites in 3 out of 4 genes (data not shown). Glo-
bally, these findings underscore the efficiency and accur-
acy of ChIP-Seq and expression array technologies to
define a Pax8-dependent gene network, which allowed
us to identify biological functions of Pax8 in thyroid
cells.Discussion
Despite the known relevance of the transcription factor
Pax8 for adult thyrocyte physiology, few data have been
published concerning Pax8 target genes other than key
thyroid-related genes (Tg, Tpo, and Nis). The transcrip-
tional output of Pax8 during thyroid development is un-
known but essential, given that thyroid follicular
precursors are not formed in Pax8 null mouse embryos,
which ultimately impairs the formation of follicle struc-
tures and thyroid hormone biosynthesis [5].
With regard to its link to tumour development, Pax8
expression decreases or is lost in follicular thyroid car-
cinomas as well as in oncogene-transformed thyroid cells
[31]. Moreover, several well-known tumour suppressors,
including TP53 [32] and WT1 [33], have been defined as
Pax8 targets, and cytoplasmic Pax8 staining has been
positively associated with tumour size, metastasis, local
invasion, recurrence, or persistence in the thyroid [34].
Taking into account all these premises, and in order to
better understand the role of Pax8 in the maintenance of
thyroid function, we decided to explore the transcrip-
tional profile of Pax8-silenced thyroid PCCl3 cells, and
to integrate these signals with genome wide cis-regula-
tory studies. Thus, our experimental design combined
putative and novel Pax8 binding sites with analysis of ac-
tual target gene expression regulation, a strategy success-
fully used for identifying direct targets for other
transcription factors [35,36].
Our unbiased mapping of Pax8 binding sites along the
rat genome has identified a large number of DNA
sequences that are occupied in living thyrocytes. More-
over, this is the first study addressing in vivo genome-
wide mapping of Pax8-DNA binding sites, and the Pax8
consensus binding motif here defined encompasses
motifs described by previous reports focused either on
single gene regulation [7,12] or on Paired-box DNA
motif characterization [13,14]. The ChIPSeq approach
also led to significant immunoprecipitation of genomic
sequences containing CpG islands, as well as CpG dinu-
cleotides. Extensive literature has linked the location of
CpG islands and GC-enriched regions to transcriptionallypermissive chromatin [37,38], which could lend support to
a relevant role of Pax8 in the transcriptional output of the
thyrocyte. About half of all CpG islands self-evidently con-
tain TSSs, while the other half (known as “orphan” CpG
islands) are either within or between characterized tran-
scription units and have unknown significance [11,38]. Des-
pite a lack of association to annotated promoters, “orphan”
CpG islands have been associated to transcriptional initi-
ation and dynamic expression during development [39]. In
agreement with this, we found significant Pax8 binding to
orphan CpG islands in intronic regions and a preferential
binding to such islands 10–100 kb upstream or downstream
of a transcription start site. In fact, genomic studies indicate
that almost half of the human coding genes have alternative
promoters [40] and that transcription factor binding sites
(TFBSs) in classically defined promoter regions may repre-
sent a minority of genomic binding sites [41]. Moreover,
this latter report clearly demonstrated an association be-
tween TFBSs and the expression of non-coding RNAs,
which could be modulating the expression of the gene
encoded by the opposite strand. Less directly, a subset of
intergenic H3K4me3 peaks, many of which are likely to cor-
respond to orphan CpG islands, were found to represent
TSSs for long non-coding RNAs [42]. Our findings suggest
that Pax8 binds orphan CpG islands that could represent al-
ternative promoters of nearby annotated genes [43] or
ncRNAs that regulate gene expression.
Otherwise, Pax8-dependent ChIP-Seq data demonstrated
an enrichment of genomic regions with overrepresentation
of general transcriptional regulatory elements (Human
MTE and Drosophila MTE, Inr-DPE and BRE). MTE con-
stitutes a core promoter element (~20-30 nt downstream of
the TSS) associated with RNA polymerase II-mediated tran-
scription [44,45]. Furthermore, human orphan CpG islands
have been associated with RNA polymerase II binding sites
[39]. On the other hand, Inr-DPE and BRE elements repre-
sent functional binding sites for TFIIB and TFIID (tran-
scription initiation factor IIB and IID, respectively), which
are main components of the basal transcription machinery
[46]. Interestingly, Jin et al recently described synergistic
MTE-Inr-BRE transcriptional modules in more than 9,000
orthologous mouse and human genes [47]. Whereas func-
tional experiments should be performed to demonstrate an
interaction of Pax8 with these general core elements, our
data underscore the importance of synergistic interactions
between core promoter elements and tissue-specific TFs to
ultimately modulate gene expression.
Potential Pax8 partners in transcriptional regulation
2Apart from the classical view of TFs interacting with
promoter regions, TFs could activate gene expression by
interacting with common lineage-specific TFs and/or
binding to distal regions (enhancers). Synergistic effects
of Pax8 and AP1 proteins have been shown to occur in
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along the NUE element [7], and AP1 and PAX proteins
also interact to cooperate in the modulation of transcrip-
tion of other genes [16]. Accordingly, we observed an
overrepresentation of binding motifs related to NRF-1
(Nuclear respiratory factor-1), and several AP1 members
(c-FOS, BATF3, and c-JUN) were differentially expressed
in Pax8-deprived thyroid cells. However, no significant
findings were obtained for other transcription factors
described to act synergistically with Pax8, such as Nkx2-
1 and TAZ/WWTR1 proteins [48], indicating that this
cooperative transcriptional role could be restricted to
specific loci rather than representing a global transcrip-
tion phenomenon in thyroid cells.
Functional studies described in the present paper con-
firmed physical in vivo interactions between Pax8 and
CTCF or Sp1 in thyrocytes. These novel partners were fur-
ther demonstrated to modulate the effect of Pax8 on the
transcription of the NIS gene, thus confirming that these
interactions are functionally relevant. Evidence has been ac-
cumulating concerning the role of CTCF in the establish-
ment of intra-chromosomal loops which ultimately mediate
protein-protein contacts between distal complexes and the
general transcription machinery [49,50]. On the other hand,
Sp1 is a ubiquitously expressed transactivator, which physic-
ally interacts with several components of TFIIB and TFIID
(mentioned above as potential Pax8 interacting proteins)
and factors related to epigenetic events, such as histone
deacetylases and p300/CBP histone acetyltransferase [51].
Interestingly, several studies have described synergistic
interactions between Pax8 and p300 acetyltransferase for
enhancing the transcriptional activity of thyroid-related
genes [52,53]. Taking into account this complete transcrip-
tional scenario, our data describe potential interactions of
Pax8 with both common TFs and core elements, which
could cooperate in chromatin remodeling for transcrip-
tional regulation in thyroid cells.Identification of biological processes controlled by Pax8
in thyroid cells
Pax8 has been mainly associated to thyroid differentiation
and development through its transcriptional role in key thy-
roid-related genes [54,55]. At this regard, we observed a
downregulation of DIO1 after abolishing Pax8 (Additional
file 5), which potentially binds to a critical region for seleno-
cystein insertion in the DIO1 mRNA. Data were recently
provided indicating that TSH tightly regulates DIO1 expres-
sion in thyroid cells through Pax8-dependent DIO1 mRNA
stabilization (S.G. Leoni; unpublished observations). More-
over, gene expression profiling in normal versus malignant
thyroid tissues demonstrated a downregulation of DIO1
and DIO2 [56], which could be linked to Pax8 loss during
cancer progression.Intriguingly, Pax8 modulates the expression of several
genes involved in carcinogenesis and thyroid malignancies
(phosphatidyl-inositol/insulin and MAPK pathways) and
cell cycle processes (CDKN2B, CCNB1 and CCNB2, among
others) (Additional file 11). These findings are in accord-
ance with previous studies in which Pax8 expression was
abolished in the differentiated thyroid cell line FRTL5
[20,57]. Our data would also explain the biological mechan-
ism underlying the partial decrease in thyrocyte prolifera-
tion in response to both IGF-I and TSH (main regulators of
thyroid proliferation and differentiation) after both Nkx2.1
and Pax8mRNA silencing [57].
DNA-related biological processes involved a plethora
of functional categories (replication, repair and metabol-
ism), highlighting the novel finding of Brca1-dependence
on Pax8. In this regard, Shih et al described that BRCA1
and BRCA2 germline mutations were twice as common
in individuals developing a second non-ovarian carcin-
oma, with follicular thyroid carcinoma being one of the
most frequent secondary tumours [18]. This finding can
be of great relevance in the development of sporadic thy-
roid tumors, given that, as mentioned before, Pax8 ex-
pression is decreased or lost in thyroid tumours.
Recent reports have associated the transcription factors
Pax2 and Pax5 with increased capabilities for cell motility
and adhesion in human cancer [58,59]. In parallel with
these Pax-related functions, we observed significant expres-
sion changes of loci involved in cell motion/adhesion, not-
ably the Pax8 effect on NCAM1 (neural cell adhesion
molecule 1) transcription. NCAM1 and other components
of adherens junctions, such as cadherins, have been
described to be essential for maintaining cell polarity and
epithelial integrity [60]. Interestingly, Cadherin-16 (Cdh16/
Ksp-cadherin) was recently proposed to play a TSH-regu-
lated role in thyroid development [61], and its expression
and promoter activity is controlled by Pax8 [20,62]. We
have not only confirmed transcriptional regulation of
Cdh16 by PAX8, but also defined additional PAX8-
dependent genes that could be essential for thyroid cell po-
larity (MYO5b and Rab17, among others). In this regard,
germline mutations in MYO5b have been associated with
disruption of epithelial cell polarity in MVID (MIM251850)
[23]. This role is exerted via its involvement in vesicle traf-
ficking through direct interactions with Rab GTPase pro-
teins, such as RAB11a and RAB8a. Further functional
studies should be performed to evaluate potential Myo5b
interactions with RAB17, another Rab GTPase protein
involved in membrane trafficking and confirmed as a Pax8
target in the present study.
Conclusions
State-of-the-art cis-regulatory sequencing studies have been
combined with mRNA silencing and expression arrays to
further characterize the functional relevance of TF-
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tional output. In our study, we describe Pax8 as a master
regulator of key cellular processes for thyrocyte biology, in-
cluding cell cycle regulation, DNA repair, replication and
metabolism, and cell polarity, and define a large set of genes
whose expression is modulated by Pax8. However, only a
minor fraction (6.4%) of the Pax8 binding sites identified
are close to TSSs and correlate with altered mRNA expres-
sion, in agreement with studies carried out on other TFSs
(1-10%) [35,36]. This moderate percentage may be
explained by the Pax8 binding site distribution, where most
of the binding sites are related with orphan CGI regions. In
this regard, our study demonstrates Pax8 binding sites in
regions distal to TSSs, preferentially in intronic regions,
which highlights a potential role as a distal or alternative
transcriptional regulator, although this does not rule out in-
direct regulation. Distal regulation by Pax8 is supported by
the interaction with chromatin remodeling factors such as
CTCF and Sp1 described in the present study. Therefore,
these findings suggest a new function of Pax8 as a chroma-
tin remodeling factor in thyroid follicullar cells, which
should be validated and elucidated in future studies.
Methods
Cell culture and plasmids
PCCl3 cells are a continuous line of thyroid follicular
cells derived from Fischer rats that express the thyroid-
specific genes Tg, Tpo, and Nis, as well as the thyroid-
specific transcription factors Nkx2.1, Foxe1, and Pax8
[63]. They were grown in Coon’s modified Ham’s F-12
medium supplemented with 5% donor calf serum and a
six-hormone mixture [64]. For transfection assays, HeLa
cells were used and cultured as described [65].
The 2,854-bp DNA fragment of the rat Nis promoter
(pNIS-2.8) which contains the NUE region with two
Pax8 binding sites was cloned in our laboratory [17]. Full
length Pax8, Sp1, and CTCF were subcloned respectively
in pcDNA3.1+, pBS and pcDNA1 Neo, and have been
previously described [66-68].
Chromatin immunoprecipitation
ChIP samples were prepared from PCCl3 cells as follows:
cultures of 10 × 106 cells were cross-linked with 1% for-
maldehyde for 10 minutes at room temperature. Cross-
linking was stopped by the addition of glycine to a final
concentration of 125 mM, and cells were washed twice
with PBS. The cell pellet was resuspended consecutively
in ChIP lysis buffers [69] and sonicated for 90 minutes
(30 seconds high frequency pulsing followed by 30 sec-
onds resting) using the Bioruptor sonicator (Diagenode,
Denville, NJ) to produce chromatin fragments of 200–
500 bp on average. After isolating the sheared chromatin,
we incubated it with Pax8 antibody-coated magnetic
beads. To prepare these beads, 100 μl of magnetic sheepanti-rabbit IgG beads (Invitrogen, Carlsbad, CA) were
incubated overnight with 10 μg polyclonal anti-mouse
Pax8 antibody (Biopat, Milan, Italy), that recognizes also
rat Pax8 at 4°C. The following day, the beads were rinsed
and added to the sheared chromatin and incubated over-
night at 4°C. Samples were then rinsed five times with
RIPA buffer, and the antibody was stripped from the
beads by incubating in 1% SDS at 65°C for 15 minutes;
cross-linking was reversed by incubating overnight at
65°C. The next day, samples were sequentially treated
with RNAse A and Proteinase K, phenol-chloroform
extracted, ethanol precipitated in the presence of
20 μg glycogen, and resuspended in 50 μl 10 mM Tris
pH 8.0. Procedure controls included an input condi-
tion, obtained before DNA-protein complex sonication
and further used during ChIP-Seq assays as
normalization sample, and non-immunoprecipitated
DNA (non-IP DNA), which was obtained just prior to
Pax8 immunoprecipitation.
Before sequencing, Pax8-IP DNA (IP) was used to con-
firm enrichment of target DNA fragments (Additional file
13) by means of real time-PCR, using as positive IP controls
both the Nis upstream enhancer element (NUE) and Tpo
promoter sequences [7,9]. Negative controls of Pax8 bind-
ing to genomic DNA included promoter areas of Gad1
(glutamate decarboxylase 1) and Afm (afamin or alpha-albu-
min), and a region of the Nis locus that does not bind Pax8.
PCR reactions were assembled in triplicate with SYBR
Green ER qPCR Supermix (Invitrogen, Carlsbad, CA) and
run on an Applied Biosystem 7500 Real Time PCR system.
The enrichment of target sequences in ChIP material was
calculated relative to the Afm negative control, and normal-
ized to their relative amplification in non-IP DNA.
Illumina high-throughput sequencing
After verifying Pax8 target enrichment, IP and non-IP
DNAs were modified for sequencing following the ChIP-
Seq manufacturer’s protocol (Illumina, San Diego, CA).
Briefly, DNAs were blunted with a combination of T4
DNA polymerase, Klenow polymerase, and T4 PNK.
Then, a single 3′-end “A” base was added using Klenow
exo (3′-to-5′ exo minus). Adapters provided by Illumina
were ligated to the ends of the modified DNA before size
selection of 200-bp fragments via polyacrylamide gel
electrophoresis followed by extraction. The isolated
DNA samples were used as the template for amplifica-
tion by 18 cycles of PCR, and used for cluster generation
on the Illumina Genome Analyzer II. Amplified products
were column-purified with the QIAquick PCR Purifica-
tion Kit (Qiagen, Dusseldorf, Germany) and assayed for
quantity and quality with the Agilent 2100 Bioanalyzer
(Agilent Technologies, Santa Clara, CA).
The 50 bp sequence reads were aligned to the rat
genome (rn4; NCBI build 4) using the MIRO pipeline
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allowing 2 mismatches, and aligned tags were con-
verted to BED format and used for identification of
binding sites. In order to visualize the data in the
University of California Santa Cruz genome browser
(http://genome.ucsc.edu), the sequence reads were
directionally extended to 300 bp, and for each base
pair in the genome the number of overlapping se-
quence reads was determined and averaged over a
10 bp window. All sequencing data can be down-
loaded from Gene Expression Omnibus (GEO) under
accession number GSE26938.
Peak finding and data analysis
MACS program (Model-based Analysis for ChIP-Seq,
v.1.4.1) was used with default parameters to determine
enriched Pax8 binding regions using non-IP DNA as
control. PeakAnalyzer software [70] was assessed to
identify functional elements proximal to the immunopre-
cipitated peaks using the annotation of the Ensembl re-
lease 63 [71] on the RGSC genome assembly v3.4.
The distance correlation analysis was done with the
GenomeInspector tool of the Genomatix suite (Genoma-
tix Software GmbH, Munich, Germany), within +/−10Kb
from the middle of the CpG islands and simple nucleo-
tide repeats. CpG islands and simple nucleotide repeat
coordinates were obtained from the UCSC Genome
Browser [72].
Motif search
We used two approaches for motif search in the
Pax8 binding sites defined by MACS. The first
method, based on MEME-ChIP [73] and focusing on
the central 100 bp portion of each sequence, was
used for the 500 peaks with the best FDR. The
TOMTOM program was used to compare known
transcriptional motifs with the motifs identified by
MEME-ChIP [74]. On the other hand, the RegionMi-
ner tool of the Genomatix suite (Genomatix Software
GmbH, Munich, Germany) identified the most over-
represented motifs, based on the background of
occurrences of the transcription factor binding sites
(TFBSs) within the whole sequence of the rat genome
(rn4; NCBI build 4); we compared these to the Pax8
binding regions identified by MACS. The motifs were
ranked by the Z-score/fold change to obtain the most
relevant sites [15].
Coimmunoprecipitation assays
Polyclonal antibodies (1 μg) were bound to Dyna-
beads (Invitrogen, Carlsbad, CA) and incubated with
200 μg of nuclear proteins extracted as described
[75] from PCCl3 thyroid cells. The incubation was
performed in 300ul of Immunoprecipitation (IP)buffer (20 mM HEPES pH 8, 10 mM KCl, 0,15 mM
EGTA, 0,15 mM EDTA, 150 mM NaCl, 0.1% NP-40
with a cocktail of protease inhibitors (Roche, Man-
hein Germany)). After washing with IP buffer, pro-
teins were eluted in 20 μl of Laemmli sample buffer
and boiled for 10 minutes. The immunocomplexes
were analyzed by SDS-PAGE and then immuno-
blotted using anti-Pax8 (BioPat, Milan Italy) and anti-
Sp1 (Santa Cruz Biotechnology Inc., Santa Cruz, CA)
antibodies. In the case of CTCF and prior to CoIP,
we transfected into PCCl3 cells an expression vector
containing the full-length human CTCF, as the anti-
body used (Upstate Biotechnology, Waltham, MASS)
recognized the human form more specifically.
Promoter activity assays
HeLa cells were transiently transfected using calcium
phosphate with 1 μg of pNIS-2.8 reporter alone or in
combination with 0.5 μg of expression vectors for
Pax8, Sp1 and CTCF as indicated in the text. The
Renilla luciferase-encoding pRL-CMV vector (50 ng)
was used to correct for transfection efficiency. Forty-
eight hours after transfection cells were harvested,
lysed, and analyzed for firefly and renilla luciferase ac-
tivities by the Dual-Luciferase reporter assay system
(Promega, Madison WI). Promoter activity was deter-
mined as the ratio between firefly and renilla lucifer-
ase and represented as relative luciferase activity. The
results were expressed as the mean ± SD of three in-
dependent experiments, each performed in triplicate.
Data were analyzed with GraphPad Prism (Intuitive
Software for Science, San Diego, CA). Statistical sig-
nificance was determined using an Anova one-way
test, and differences were considered significant at a
P< 0.05.
Expression arrays
The Pax8-dependent gene expression study was performed
in differentiated PCCl3 thyroid cells by means of expression
arrays (Agilent rat whole genome 44 K arrays). For this pur-
pose, we generated three different conditions to finally es-
tablish two main comparisons: wild type vs. Pax8-silenced
PCCl3 cells (siPax8 PCCl3), and scrambled siRNA-treated
(siScramble PCCl3) vs. Pax8-silenced PCCl3 cells. Given
that each comparison was performed using quadruplicates
and dye-swaps (Cy3 and Cy5 fluorochromes), our experi-
mental design included sixteen independent competitive
hybridizations (Additional file 14).
Transient transfections of PCCl3 cells were performed
using Lipofectamine 2000 (Invitrogen, Carlsbad, CA),
both for scrambled and for Pax8 siRNA conditions
(10 ng siRNA /ml) (Dharmacon, Denver, USA). Pax8 si-
lencing was tested by means of western blotting using a
polyclonal Pax8 mouse antibody (Biopat, Milan, Italy) at
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(Additional file 15). Once the 48 hours condition was
defined as the best time point for Pax8 silencing, we per-
formed additional transfections to isolate total RNA
using TRIzol reagent (Invitrogen, Carlsbad, CA) for each
condition considered (siPax8, scrambled siRNA and
PCCl3 cells treated with lipofectamine) following the
manufacturer’s recommended protocol. RNA quality was
evaluated with the Agilent 2100 Bioanalyzer and later
amplified and labelled by using the Low RNA Input Lin-
ear Amplification Kit PLUS, Two-Color (Agilent Tech-
nologies, Palo Alto, CA). Briefly, for each sample 2 μg of
total input RNA were amplified in two rounds of amplifi-
cation following the manufacturer’s instructions. First
strand cDNA synthesis and amplification reactions were
carried out using random and T7 primers, respectively.
During the 2-hour in vitro transcription, Cy3- or Cy5-la-
beled CTP was incorporated into each amplified RNA
(cRNA). Products of the reaction were then purified
using RNAeasy mini spin columns (Qiagen, Dusseldorf,
Germany). Hybridization and slide and image processing
were carried out according to the manufacturer’s instruc-
tions (Two-Color Microarray-Based Gene Expression
Analysis protocol). In each experiment, 825 ng of con-
trasting cRNA samples were fragmented at 60°C for
30 min and hybridized at 65°C for 17 hr. The slides were
scanned at a 10 μm resolution using the Agilent
G2565BA Microarray Scanner (Agilent Technologies,
Palo Alto, CA). Signal quantification was carried out
with Feature Extraction 9.1 software (Agilent Technolo-
gies, Palo Alto, CA), using default analysis parameters
for Agilent’s whole rat genome 44 K gene expression
arrays. Array data were normalized using loess and quan-
tile methods for normalization within and between
arrays, respectively. Differential expression analysis was
done using Bioconductor’s limma package. At a later
stage, we used the annotate package and the data base
rgug4131a.db to obtain the annotations of the rat gen-
ome from Agilent. Genes that showed adjusted p-values
<0.005 were considered differentially expressed both in
wild type vs. siPax8 cells and in siScramble PCCl3 vs.
siPax8 PCCl3 cells. Functional analysis of Gene Ontol-
ogy (GO) terms was carried out using the FatiGO tool
and gene set enrichment analysis was performed using
FatiScan [76,77]. All microarray data can be downloaded
from the Gene Expression Omnibus (GEO) under acces-
sion number GSE26938.
Experimental validation for ChIP-seq and expression array
data
Technical validations were performed by means of real-
time PCR to verify the Pax8-dependency of 7 loci, which
showed significant results for both expression profiling
and ChIP-Seq, independently of the peak location alongthe considered gene. After performing an independent
Pax8-chromatin IP, we obtained genomic DNA from IP,
non-IP, and input samples, which were further used to
amplify specific fragments contained in IP peaks (Add-
itional file 13). The immunoprecipitation ratio for IP
peaks was estimated comparing IP versus non-IP ampli-
fication values using as normalizing regions those men-
tioned above (Gad1 and Afm), which were confirmed as
negative controls by the ChIP-Seq results.
siRNA transfection was done to obtain cDNA for each
of the three conditions initially considered for expression
profiling (Pax8 siRNA, scrambled siRNA, and wild type
PCCl3 cells). Expression level changes were defined in 7
down-regulated genes and in 4 up-regulated genes by
means of real-time PCR for fragments specifically ampli-
fying transcripts of interest (Additional file 16), using
GAPDH as a control for target gene expression
normalization.
Additional files
Additional file 1: (A). Pax8 chromatin immunoprecipitation validation
performed to confirm enrichment of target DNA fragments by means of
real-time PCR. Sequences belonging to the Nis upstream enhancer element
(NUE) [7] and Tpo promoter sequences [9], previously described as Pax8
binding sites in rat thyroid cells, were used as positive controls. (B). ChIP-Seq
results with regard to the Nis locus were visualized in the UCSC genome
browser. Significant immunoprecipitated peak corresponding to MACS
program included the Nis upstream enhancer (NUE), previously described to
be regulated by Pax8 (underlined red letters).
Additional file 2: ChIP-Seq MACS data: Excel file containing genomic
coordinates of 13,151 rat genomic regions significantly immunoprecipitated
according to the MACS ChIP program.
Additional file 3: ChIP seq peaks used for MEME/TOMTOM consensus
motif analysis: Genomic coordinates of the 500 most significant ChIP peaks
used to verify Pax8-dependent immunoprecipitation and to delineate the
consensus Pax8 DNA binding site.
Additional file 4: DNA binding motifs overrepresented in Pax8 IP
peaks. Genomatix matrices significantly associated to Pax8 MACS peaks.
Overrepresentation (genome) column represents overrepresentation values of
these matrices in our IP peaks compared to their presence along the rat
genome, and Z-Score (genome) column indicates association value of Pax8-
immunoprecipitated DNA for each considered DNA matrix.
Additional file 5: Expression data of wt and scrambled conditions vs.
siPax8 conditions and association with ChIP-Seq data. Common probes
(+/− 1kb) Excel sheet includes expression data for the 78 probes common
to both expression comparisons (wt and siScramble conditions vs. siPax8;
p<0.005) and belonging to genes showing a significant IP peak within 1kb
of a TSS. Additional Excel sheets include significant probes for each array
comparison.
Additional file 6: FatiScan gene set enrichment analysis. Excel file
containing Gene Ontology (GO) terms commonly overrepresented in both
expression array comparisons (datasheet “Common GO terms") and their
adjusted p-values. This file also contains datasheets showing GO terms
statistically significant for each individual comparison (WT or SCR sign GO
biol. process).
Additional file 7: FatiScan gene set enrichment analysis for scrambled
and wild type conditions vs. siPax8 conditions. FatiScan image showing
enriched GO terms in siScramble vs. siRNAPax8 and wt vs. siRNAPax8
comparisons, respectively.
Additional file 8: FatiScan gene set enrichment analysis for scrambled
and wild type conditions vs. siPax8 conditions. FatiScan image showing
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http://www.biomedcentral.com/1471-2164/13/147enriched GO terms in siScramble vs. siRNAPax8 and wt vs. siRNAPax8
comparisons, respectively.
Additional file 9: Significant biological processes among
underexpressed probes. FatiGO images showing overrepresented
biological processes among common downregulated (n=633) probes for
both expression array comparisons.
Additional file 10: Significant biological processes among
overexpressed probes. FatiGO images showing overrepresented
biological processes among common upregulated (n=565) probes for
both expression array comparisons.
Additional file 11: Overrepresented KEGG pathways among under-
and overexpressed probes. KEGG pathways enriched among common
downregulated (n=633) and upregulated (n=565) probes for both
expression array comparisons.
Additional file 12: UCSC genome browser images showing significant
Pax8 IP peaks for closely positioned loci which were detected to be
significantly deregulated in expression arrays (p<0.005).
Additional file 13: Oligonucleotides used for immunoprecipitation
validation prior to performing high throughput sequencing (including
positive and negative Pax8 immunoprecipitation controls), or for
experimental validation of ChIP-Seq
Additional file 14: Schematic representation of experimental design
followed for whole genome rat expression arrays. Both comparisons
(PCCl3-siPax8 vs. PCCl3-wt and PCCl3-siPax8 vs. PCCl3-siScramble)
included four different biological replicates that were cross-labelled with
either Cy3 or Cy5.
Additional file 15: Immunoblot demonstrating Pax8 downregulation in
siPax8 conditions (siPax8) versus control conditions, including the no
transfection condition (wt) and siScramble PCCl3-transfected cells
(siScramble). Time points include 24 and 48 hours.
Additional file 16: Oligonucleotides used for experimental validation of
expression arrays.
Abbreviations
TFs: transcription factors; ChIP-Seq: Chromatin immunoprecipitation followed
by massive sequencing; IP: immunoprecipitated sample; Non-IP: non-
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CpG: CpG island; GO: Gene Ontology.
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